Advertisement
TFX vs XRAY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFX is a Hold and XRAY is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TFX’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).
- TFX’s FA Score: 1 green, 4 red.
- XRAY’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TFX’s TA Score shows that 5 TA indicator(s) are bullish while XRAY’s TA Score has 5 bullish TA indicator(s).
- TFX’s TA Score: 5 bullish, 5 bearish.
- XRAY’s TA Score: 5 bullish, 5 bearish.
Price Growth
TFX (@Pharmaceuticals: Other) experienced а -2.06% price change this week, while XRAY (@Pharmaceuticals: Other) price change was -6.03% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.27%. For the same industry, the average monthly price growth was +0.89%, and the average quarterly price growth was +24.99%.
Reported Earning Dates
TFX is expected to report earnings on Feb 19, 2026.
XRAY is expected to report earnings on Feb 26, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.27% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| TFX | XRAY | TFX / XRAY | |
| Capitalization | 4.52B | 2.4B | 189% |
| EBITDA | 52.3M | -433M | -12% |
| Gain YTD | -16.118 | 4.987 | -323% |
| P/E Ratio | 29.08 | N/A | - |
| Revenue | 3.19B | 3.62B | 88% |
| Total Cash | 354M | 1.27B | 28% |
| Total Debt | 2.77B | 2.48B | 112% |
TFX | XRAY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 4 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 26 Undervalued | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 97 | |
PRICE GROWTH RATING 1..100 | 65 | 60 | |
P/E GROWTH RATING 1..100 | 79 | 85 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
XRAY's Valuation (4) in the Medical Specialties industry is in the same range as TFX (26). This means that XRAY’s stock grew similarly to TFX’s over the last 12 months.
XRAY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TFX (100). This means that XRAY’s stock grew similarly to TFX’s over the last 12 months.
TFX's SMR Rating (94) in the Medical Specialties industry is in the same range as XRAY (97). This means that TFX’s stock grew similarly to XRAY’s over the last 12 months.
XRAY's Price Growth Rating (60) in the Medical Specialties industry is in the same range as TFX (65). This means that XRAY’s stock grew similarly to TFX’s over the last 12 months.
TFX's P/E Growth Rating (79) in the Medical Specialties industry is in the same range as XRAY (85). This means that TFX’s stock grew similarly to XRAY’s over the last 12 months.
| TFX | XRAY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 55% | 1 day ago 54% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 47% |
| Momentum ODDS (%) | 1 day ago 51% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 56% | 1 day ago 73% |
| TrendWeek ODDS (%) | 1 day ago 73% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 72% | 1 day ago 58% |
| Advances ODDS (%) | 7 days ago 55% | 14 days ago 55% |
| Declines ODDS (%) | 1 day ago 74% | 1 day ago 73% |
| BollingerBands ODDS (%) | 1 day ago 55% | 1 day ago 70% |
| Aroon ODDS (%) | 1 day ago 73% | 1 day ago 51% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RIGIX | 47.80 | 0.18 | +0.38% |
| American Funds Intl Gr and Inc R5E | |||
| MOINX | 29.47 | N/A | N/A |
| NYLI WMC Small Companies Investor Class | |||
| APHJX | 19.66 | -0.05 | -0.25% |
| Artisan International Small-Mid Instl | |||
| PTMQX | 23.55 | -0.23 | -0.97% |
| PGIM Quant Solutions Large-Cap Cor Eq R6 | |||
| AVEAX | 16.42 | -0.20 | -1.20% |
| Ave Maria Growth Focused | |||
TFX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TFX has been loosely correlated with XRAY. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then XRAY could also see price increases.
| Ticker / NAME | Correlation To TFX | 1D Price Change % | ||
|---|---|---|---|---|
| TFX | 100% | -0.96% | ||
| XRAY - TFX | 56% Loosely correlated | -1.72% | ||
| A - TFX | 51% Loosely correlated | -2.40% | ||
| RVTY - TFX | 47% Loosely correlated | -5.57% | ||
| AZTA - TFX | 44% Loosely correlated | -1.65% | ||
| TNDM - TFX | 44% Loosely correlated | -3.24% | ||
More | ||||
XRAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, XRAY has been closely correlated with NVST. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if XRAY jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To XRAY | 1D Price Change % | ||
|---|---|---|---|---|
| XRAY | 100% | -1.72% | ||
| NVST - XRAY | 67% Closely correlated | -1.50% | ||
| ALGN - XRAY | 53% Loosely correlated | -4.02% | ||
| QDEL - XRAY | 50% Loosely correlated | +1.19% | ||
| BAX - XRAY | 50% Loosely correlated | +0.20% | ||
| KIDS - XRAY | 48% Loosely correlated | -1.85% | ||
More | ||||